RFK Jr.’s Trial Lawyer Ties Raise Red Flags
We must ensure that all future health decisions are made with the best interests of all Americans in mind — not the financial motives of profit-seeking plaintiffs’ lawyers.
(1st Circ., filed April 11, 2018): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants had packaged it more efficiently does not describe a cognizable injury in fact, and therefore, they lack standing. Accepting plaintiffs’ theory would invite abusive class-action litigation.
On August 27, 2018, the court held that defendants could not change the drop size of an FDA-approved drug without prior FDA approval and thus that plaintiffs’ state-law claims were preempted.
We must ensure that all future health decisions are made with the best interests of all Americans in mind — not the financial motives of profit-seeking plaintiffs’ lawyers.
Proposed Reforms Aim to Slash $1,372 Annual ‘Tort Tax’ for Every Georgian
Nuclear Verdicts® and Insurance Fraud Plague State’s Legal System
New Report Ranks Seattle-Area Courts Among Worst in US
$1,046/Person ‘Tort Tax’ — Court Expands Liability, Michiganders Pay
Courts Threaten Preemie Formula Access, Residents Pay $1,475/Person/Year ‘Tort Tax’